USD
$0.00
(0.00%
)At Close (As of Sep 15, 2025)
-
Market Cap
-
P/E Ratio
-
EPS
$1,213.00
52 Week High
$6.34
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Total Assets | $1.4M |
Total Current Assets | $170K |
Cash And Cash Equivalents At Carrying Value | $17K |
Cash And Short Term Investments | $17K |
Inventory | - |
Current Net Receivables | $67K |
Total Non Current Assets | $1.3M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $86K |
Other Non Current Assets | - |
Total Liabilities | $7.5M |
Total Current Liabilities | $6.5M |
Current Accounts Payable | $590K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | - |
Total Non Current Liabilities | $1M |
Capital Lease Obligations | $87K |
Long Term Debt | $968K |
Current Long Term Debt | $2M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | - |
Other Current Liabilities | $1.7M |
Other Non Current Liabilities | - |
Total Shareholder Equity | -$6.1M |
Treasury Stock | - |
Retained Earnings | -$54M |
Common Stock | - |
Common Stock Shares Outstanding | $26M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company is headquartered in Princeton, New Jersey.